Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
New movies to watch this weekend: See 'The Running Man' in theaters, rent 'One Battle After Another,' stream 'Nobody 2' on Peacock - 2Surveys of Music Collections by Film Stars
- 3Israel strikes Iranian nuclear development facilities, Tehran vows retaliation
- 4Ageless Tastefulness: An Outline of Valuable Gemstones and Adornments
- 5Dinosaur collagen used to create one-of-a-kind handbag
- Most loved Seared Chicken: Which Chain Rules?
- Warship sunk by British fleet, remains of sailor found after 225 years
- Sports Shoes of 2024: Upgrade Execution and Solace
- 6 Agreeable Earphones To Wear
- Europe picks companies to help build Argonaut moon lander
- Top 15 Web-based Entertainment Stages for Individual Marking
- Wonderful Sea shores All over the Planet
- Step by step instructions to Lessen Your Gamble of Creating Cellular breakdown in the lungs
- Tech Patterns: Contraptions That Will Shape What's in store
